Advisor Group Holdings, Inc. Akari Therapeutics PLC Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$1.69 - $2.85 $8 - $14	-5 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$1.5 - $2.02 $105 - $141	-70 Reduced 93.33%	5 $0
Q3 2020 Nov 12, 2020	SELL	$1.58 - $2.37 $1,657 - $2,486	-1,049 Reduced 93.33%	75 $0
Q2 2020 Aug 14, 2020	BUY	$1.16 - $2.61 $46 - $104	40 Added 3.69%	1,124 $2,000
Q1 2020 May 18, 2020	BUY	$1.06 - $2.16 $1,149 - $2,341	1,084 New	1,084 $2,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $59.3M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.